Casadei Gianluigi, Cartabia Massimo, Reale Laura, Costantino Maria Antonella, Bonati Maurizio
CESAV-"Angelo e Angela Valenti" Centre for Health Economics, Department of Public Health, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", Via Giuseppe La Masa, 19, 20156 Milan, Italy.
Laboratory for Mother and Child Health, Department of Public Health, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
Int J Ment Health Syst. 2017 Apr 28;11:33. doi: 10.1186/s13033-017-0140-8. eCollection 2017.
The main aim of this study was to estimate the costs associated with diagnostic assessment and 1-year therapy in children and adolescents enrolled in 18 ADHD reference centres. Data concerning 1887 children and adolescents from the mandatory ADHD registry database during the 2012-2014 period were analysed. The overall diagnostic and treatment costs per patient amounts to €574 and €830, respectively. The ADHD centre, the school as sender, and the time to diagnosis constitute cost drivers. Non-pharmacological therapy resulted as being more expensive for patients concomitantly treated with drugs (€929) compared to those treated with psychological interventions alone (€590; p = 0.006). This study gives the first and reliable estimate of the costs associated with both diagnosis and treatment of ADHD in Italy. Although costs associated with mental disorders are difficult to estimate, continuing efforts are need to define costs and resources to guarantee appropriate care, also for ADHD.
本研究的主要目的是估算在18个注意力缺陷多动障碍(ADHD)参考中心登记的儿童和青少年的诊断评估及1年治疗相关费用。分析了2012 - 2014年期间来自强制性ADHD登记数据库的1887名儿童和青少年的数据。每位患者的总体诊断和治疗费用分别为574欧元和830欧元。ADHD中心、作为信息提供者的学校以及诊断时间构成成本驱动因素。与仅接受心理干预的患者(590欧元;p = 0.006)相比,同时接受药物治疗的患者接受非药物治疗的费用更高(929欧元)。本研究首次对意大利ADHD诊断和治疗相关费用进行了可靠估算。尽管精神障碍相关费用难以估算,但仍需要持续努力来确定成本和资源,以确保为ADHD患者提供适当的护理。